Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Nat Med. 2019 Oct 7;25(10):1534–1539. doi: 10.1038/s41591-019-0593-1

Fig. 1. PV-CTC detection in early NSCLC.

Fig. 1

a, TRACERx consort diagram. 149 patients consented for pulmonary vein blood sampling between June 2014 and March 2017. 27 samples were excluded because of failures in CellSearch® enrichment and enumeration. 22 patients were defined ineligible post-surgery and the remaining 100 patients constituted the final cohort for PV-CTC enumeration. b, Distribution of the number of PV-CTCs enumerated by CellSearch® from 100 patients with early NSCLC. LUAD (blue circle) and non-LUAD (red circle) patients are indicated. c, Heat map showing clinicopathological and PV-CTC detection data; Patients are stratified according to PV-CTC detection. Histological disease type is indicated by coloured bar above the heatmap.